Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP2 | P42575 | 1/20 | 0.67 |
| ▸ | NAAA | Q02083 | 1/20 | 0.52 |
| ▸ | FAAH | O00519 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | CTSD | P07339 | 1/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13819835 | 0.92 | CASP2 (0.74) | CASP2NAAAFAAHMEN1KMT2A | |
| SCHEMBL7769416 | 0.89 | CASP2 (0.57) | CASP2NAAAFAAHMEN1KMT2A | |
| SCHEMBL7537764 | 0.86 | CASP2 (0.86) | CASP2NAAAFAAHMEN1KMT2A | |
| SCHEMBL14576993 | 0.86 | CASP2 (0.78) | CASP2NAAAFAAHMEN1KMT2A | |
| SCHEMBL11213979 | 0.86 | CASP2 (0.60) | CASP2NAAAFAAHMEN1KMT2A | |
| SCHEMBL21587881 | 0.86 | FAAH (0.68) | CASP2NAAAFAAHMEN1KMT2A | |
| SCHEMBL6684491 | 0.85 | FAAH (0.61) | CASP2NAAAFAAHDNM1SLC6A5 | |
| SCHEMBL1298169 | 0.85 | CASP2 (0.59) | CASP2NAAAFAAHMEN1KMT2A | |
| SCHEMBL6686395 | 0.85 | CASP2 (0.59) | CASP2NAAAFAAHMEN1KMT2A | |
| SCHEMBL10477936 | 0.84 | MEN1 (0.70) | CASP2NAAAFAAHMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3371150-B1 | PROCESS FOR PREPARING BRIVARACETAM | UCB Biopharma SRL (BE) | 2021-08-18 | — | — | EP | disclosed |
| WO-2017076737-A1 | CONTINUOUS PROCESS FOR PREPARING BRIVARACETAM | UCB BIOPHARMA SPRL (BE) | 2017-05-11 | — | — | WO | disclosed |
| WO-2017076738-A1 | PROCESS FOR PREPARING BRIVARACETAM | UCB BIOPHARMA SPRL (BE) | 2017-05-11 | — | — | WO | disclosed |
| EP-0765879-B1 | 13-Substituted milbemycin 5-oxime derivatives, their preparation and their use against insects and other pests | SANKYO CO (JP) | 2001-02-14 | — | — | EP | disclosed |
| US-5861429-A | MITICIDES AND ANTHELMINTICS | SANKYO COMPANY, LIMITED (JP) | 1999-01-19 | — | — | US | disclosed |
| EP-0765879-A1 | 13-Substituted milbemycin 5-oxime derivatives, their preparation and their use against insects and other pests | SANKYO COMPANY LIMITED (JP) | 1997-04-02 | — | — | EP | disclosed |
| US-5453363-A | Solubilizing, reducing, and denaturing refractile bodies; oxidation with glutathione; genetic engineering | BOEHRINGER MANNHEIM GMBH (DE) | 1995-09-26 | — | — | US | disclosed |